ZANDRIA FREDRICK: Open Payments
NPI 1265079263 · COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$347 in 16 payments from 11 companies in 2025. Trend: 2023 $1,176 · 2024 $779 · 2025 $347
Food & beverage: $347
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 2 | $53 |
| PFIZER INC. | 2 | $48 |
| AstraZeneca Pharmaceuticals LP | 2 | $43 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $34 |
| E.R. Squibb & Sons, L.L.C. | 2 | $33 |
| Philips North America LLC | 1 | $32 |
| Alnylam Pharmaceuticals Inc. | 1 | $26 |
| Actelion Pharmaceuticals US, Inc. | 1 | $23 |
| Novo Nordisk Inc | 1 | $22 |
| Esperion Therapeutics, Inc. | 1 | $19 |
Products named: LEQVIO, VYNDAQEL, LOKELMA, JARDIANCE, CAMZYOS, Ambulatory Monitoring & Diagnostics Undivided, ONPATTRO, UPTRAVI.
Industry payments across SC — which companies pay providers there.
